Member Sign In
Member Sign Out
Drug Discovery & Development
Create a FREE account so you can:
Get the latest life sciences research and
industry news, delivered straight to your
inbox, for FREE.
Enter your Email Address to become a member:
Already have an account?
Sign in using your social networking account:
Sign in using your social networking
Forgot your password?
Genomics AI firm Genomenon acquires Boston Genetics
Genomenon on Tuesday said that it has acquired the genomics interpretation and curation firm Boston Genetics.
3D cellular models identify potential drug target for preventing Alzheimer’s
A 3D cellular model has shown that mutations affect neuronal development and may play a large role in the emergence of Alzheimer’s disease.
Gene mutations linked to drug-resistant liver cancer
Certain gene mutations could serve as markers to help physicians predict which patients with hepatocellular carcinoma are most likely to develop resistance to the drug lenvatinib.
Asep gets Canadian grant for development of peptide-based drug delivery vehicle
Asep Medical announced Friday that it has been awarded a grant by the NanoMedicines Innovation Network (NMIN) to develop a nanoparticle-formulated peptide solution as a drug delivery vehicle for treating chronic sinus infections caused by biofilms.
Stem cell-derived islet cell therapy shows promise for individuals with type 1 diabetes
An ongoing clinical trial for patients with type 1 diabetes (T1D) demonstrated the potential of stem cell-derived islet cell therapy, called VX-880, as a future treatment option for patients with type 1 diabetes (T1D), the American Diabetes Association (ADA) said on Friday.
Potential treatment for rare autoimmune disorder adapted from CAR-T therapy in study
Evidence from a small-scale clinical trial suggests that a variation of the blood cancer immunotherapy chimeric antigen receptor T-cell (CAR-T) could be adapted to treat myasthenia gravis (MG), an autoimmune disorder of the nervous system.
Biotech firm AltPep closes $53M Series B financing round
AltPep, a biotech firm developing early detection tests and disease-modifying treatments for amyloid diseases, on Friday announced the closing of a $52.9 million Series B financing round.
FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy
The U.S. Food and Drug Administration (FDA) on Thursday approved Elevidys, the first gene therapy for the treatment of pediatric patients 4 through 5 years of age with Duchenne muscular dystrophy (DMD).
Rare disease discovered after scientists probe cause of inflammatory symptoms
Researchers have discovered a rare disease by running genetic, immunologic, and molecular assays in four patients.
FDA approves new class of medicines to treat pediatric type 2 diabetes
The U.S. Food and Drug Administration (FDA) this week granted approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and exercise to improve blood sugar control in children 10 years and older with type 2 diabetes.
More Conferences »»
Nucleai, Mayo Clinic partner on digital pathology
Adaptive Biotechnologies, Genentech announce FDA acceptance of investigational new drug application
Roche launches Institute of Human Biology for human model systems to advance research and drug development
SomaLogic CEO steps down; Q4 revenue declines 18%
Mayo Clinic Laboratories, Helix collaborate to provide suite of laboratory services to biopharma customers
More articles »
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Tweets by @ScienceBoard